Company intelligence / Profile preview

Endovac Animal Health

Columbia, Missouri, United States

Ownership: Private
Development stage: Other

Overview

Endovac Animal Health manufactures and commercializes vaccines for livestock and companion animals focused on gram-negative bacteria coverage. Their flagship ENDOVAC vaccine line has been on the market since the late 1980s and is USDA-licensed for use in beef cattle, dairy cattle, swine, and equine species.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBacterin-toxoid
Industry: Veterinary

Partnerships

Kane Veterinary ServiceUniversity of Missouri

Beyond the preview

Go deeper on Endovac Animal Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endovac Animal Health.

Explore the full profile